Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes

BACKGROUND: Although opioid agonist treatments (OAT) with methadone or buprenorphine are available to treat opioid use disorders (OUD) in Ukraine, OAT acceptability and coverage remains low. Extended-release naltrexone (XR-NTX) that recently became available as another treatment option provides new...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Subst Abuse Treat
Main Authors: Makarenko, Iuliia, Pykalo, Iryna, Springer, Sandra A., Mazhnaya, Alyona, Marcus, Ruthanne, Filippovich, Sergii, Dvoriak, Sergii, Altice, Frederick L.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215516/
https://ncbi.nlm.nih.gov/pubmed/31370983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2019.05.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares